MedTrace Logo

Silicone Oil Versus Gas in PDR Patients Undergoing Vitrectomy

NCT03660384 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 302

Last updated 2021-12-02

No results posted yet for this study

Summary

Subjects receiving 16% C3F8 gas tamponade during vitrectomy will have better visual acuity and similar postoperative complications to subjects who receive silicone oil tamponade during vitrectomy.

Conditions

Interventions

PROCEDURE

PPV/SO

Subjects receive 1,000 centistoke silicone oil tamponade during vitrectomy

PROCEDURE

PPV/C3F8

Subjects receive 16% C3F8 gas tamponade during vitrectomy

Sponsors & Collaborators

  • Rush Eye Associates

    lead OTHER

Principal Investigators

  • Sloan Rush · panhandle eye group

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-04
Primary Completion
2020-03-04
Completion
2020-03-04

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03660384 on ClinicalTrials.gov